HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li-Wei Chang Selected Research

Li-Wei Chang Research Topics

Disease

3Neoplasms (Cancer)
12/2020 - 12/2010
2Nevus (Nevi)
04/2022 - 12/2020
2Melanoma (Melanoma, Malignant)
12/2020 - 05/2017
2Leukemia
12/2010 - 06/2009
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2010 - 06/2009
1Hypertrichosis
04/2022
1Musculoskeletal Abnormalities
04/2022
1Becker Nevus Syndrome
04/2022
1Hamartoma
04/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2015
1Peripheral Nerve Injuries
02/2013
1Breast Neoplasms (Breast Cancer)
06/2012
1Crush Injuries
11/2011
1Acute Promyelocytic Leukemia
06/2009
1Genetic Translocation (Chromosomal Translocation)
06/2009

Drug/Important Bio-Agent (IBA)

4MicroRNAs (MicroRNA)IBA
12/2020 - 12/2010
2Proteins (Proteins, Gene)FDA Link
05/2017 - 06/2009
2Transcription Factors (Transcription Factor)IBA
01/2015 - 02/2013
1Spironolactone (Aldactone)FDA LinkGeneric
04/2022
16-bromo-2-naphthyl sulfate (BNS)IBA
04/2022
1Long Noncoding RNAIBA
12/2020
1Untranslated RNA (Noncoding RNA)IBA
05/2017
17- chloro- 8- hydroxy- 1- (3'- iodophenyl)- 3- methyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepine (TISCH)IBA
05/2017
1Aromatase InhibitorsIBA
06/2012
1Aromatase (CYP19)IBA
06/2012
1Retinoic Acid Receptor alphaIBA
06/2009
1Messenger RNA (mRNA)IBA
06/2009

Therapy/Procedure

1Therapeutics
06/2012